angelicin has been researched along with Cystic Fibrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianchi, N; Borgatti, M; Cabrini, G; Dall'Acqua, F; Gambari, R; Lampronti, I; Mancini, I; Nicolis, E; Piccagli, L; Vevaldi, D | 1 |
| Bianchi, N; Borgatti, M; Chilin, A; dall'Acqua, F; Gambari, R; Guiotto, A; Lampronti, I; Mancini, I; Marzaro, G; Piccagli, L | 1 |
2 other study(ies) available for angelicin and Cystic Fibrosis
| Article | Year |
|---|---|
Virtual screening against nuclear factor κB (NF-κB) of a focus library: Identification of bioactive furocoumarin derivatives inhibiting NF-κB dependent biological functions involved in cystic fibrosis.
Topics: Binding Sites; Cell Line; Computer Simulation; Cystic Fibrosis; Databases, Factual; Electrophoretic Mobility Shift Assay; Furocoumarins; Humans; Hydrogen Bonding; Interleukin-8; Ligands; NF-kappa B; Protein Structure, Tertiary | 2010 |
Development of a novel furocoumarin derivative inhibiting NF-κB dependent biological functions: design, synthesis and biological effects.
Topics: Cell Line; Cystic Fibrosis; DNA; Drug Design; Furocoumarins; Gene Expression Regulation; Humans; Interleukin-8; Models, Molecular; NF-kappa B; Protein Binding; RNA, Messenger; Tumor Necrosis Factor-alpha | 2011 |